TNFSF10 and thyroid cancer: Sorafenib and Apo2L/TRAIL/TRA act in a synergistic manner in 8505C thyroid cancer cell line: Calcusyn analysis of solid tumor cell lines that were treated with sorafenib and Apo2L/TRAIL/TRA in Figure 3 that were analyzed by CellTiter-GLO.